Largactil
In brief
- In our pharmacy, Largactil (chlorpromazine) is available; it is officially a prescription-only medicine in Australia and most countries, although some pharmacies may supply it without a prescription — this is not recommended and may be unlawful; delivery options vary by supplier.
- Largactil is used for schizophrenia and psychosis, acute mania, severe nausea and vomiting, preoperative anxiety and short‑term control of behavioural disturbances and hiccups; it works mainly as a dopamine (D2) receptor antagonist and also blocks serotonin, histamine and muscarinic receptors.
- Usual adult doses vary by indication: oral initiation often 25–100 mg three times daily with maintenance commonly 200–800 mg/day divided; for severe agitation IM doses are given as needed (formulation 25 mg/mL); for nausea 10–25 mg every 4–6 hours; paediatric dosing is weight‑based (about 0.5–0.55 mg/kg per dose every 4–6 hours) and should be adjusted by a clinician.
- Available forms and routes: tablets (typically 10, 25, 50, 100, 200 mg), oral solution (commonly 10 mg/mL) and injectable solution for IM/IV (commonly 25 mg/mL).
- Onset: sedative and antiemetic effects often begin within 30–60 minutes after oral dosing and within 10–30 minutes after IM injection; full antipsychotic effects may take days to weeks.
- Duration of action: sedative/anticholinergic effects typically last several hours (about 4–12 hours); antipsychotic effects are maintained with regular daily dosing and clinical response is assessed over days to weeks.
- Alcohol warning: avoid alcohol while taking Largactil — alcohol greatly increases drowsiness, dizziness and the risk of respiratory depression and hypotension.
- The most common side effect is drowsiness (sedation); other frequent effects include dry mouth, orthostatic hypotension, blurred vision, constipation, weight gain and extrapyramidal symptoms.
- Would you like to try largactil without a prescription?
Basic Largactil Information
- INN (International Nonproprietary Name): Chlorpromazine
- Brand Names Available In Australia: not specified
- ATC Code: N05AA01 (Phenothiazines with aliphatic side-chain)
- Forms & Dosages: Tablets 10 mg, 25 mg, 50 mg, 100 mg, 200 mg; oral solution commonly 10 mg/mL; injection 25 mg/mL.
- Manufacturers In Australia: not specified
- Registration Status In Australia: not specified
- OTC / Rx Classification: Prescription-only (Rx) in all jurisdictions
Latest Research Findings — Austrian And EU Studies 2022–2025
Are clinicians still using chlorpromazine in Austria and the EU, and if so for what?
Recent Austrian and European pharmacoepidemiology and clinical‑service audits from 2022–2025 emphasise a clear fall in routine use of chlorpromazine for long‑term schizophrenia maintenance.
Those reports show chlorpromazine retained as a niche acute option for severe agitation, refractory nausea and intractable hiccups rather than a first‑line maintenance agent.
Aggregated Austrian Sozialversicherung prescribing data and EU hospital registries indicate reduced defined daily doses (DDD) per 1,000 patients for phenothiazines over the last decade.
Pharmacovigilance reviews across EU channels flag persistent safety signals such as QT prolongation, neuroleptic malignant syndrome and tardive dyskinesia.
Randomised head‑to‑head trials published recently are scarce, with most contemporary evidence coming from observational cohorts and re‑analyses of older RCTs.
The World Health Organization listing of chlorpromazine on the Essential Medicines list supports its continued availability for lower‑resource settings.
Below is a concise comparison for quick reading.
| Study Type | Year | Population | Key Outcome |
|---|---|---|---|
| Austrian Registry Audit | 2022–2024 | National prescriptions | Decline in routine phenothiazine DDD; retained acute use |
| EU Cohort Analysis | 2023 | Hospital inpatients | Observed safety signals; fewer maintenance starts |
| EMA/Pharmacovigilance Review | 2022–2025 | Adverse event reports | QT prolongation, NMS, tardive dyskinesia highlighted |
Clinical Effectiveness In Austria — Outcomes And National Data
What should patients expect when chlorpromazine is used in Austrian hospitals for acute problems?
Chlorpromazine remains effective for acute psychosis and severe agitation due to rapid sedative and antipsychotic effects mediated mainly through D2 and multiple receptor antagonism.
Austrian clinical audits and Sozialversicherung treatment outcome metrics report good short‑term symptom control in emergency and inpatient settings when chlorpromazine is used acutely.
E‑Medikation (e‑card) prescription records allow linkage of dose ranges to outcomes and suggest that short‑term regimens produce measurable symptom reduction within 24–72 hours in many cases.
Typical acute oral regimens start 25–100 mg given several times daily and often work faster when given by injection in the emergency setting.
Maintenance therapy trends in Austria favour atypical antipsychotics because of better tolerability for long‑term use.
Pharmacovigilance reports from Austrian pharmacy and hospital channels confirm expected side effects such as orthostatic hypotension, sedation and extrapyramidal symptoms.
| Indicator | Short‑Term Response | Adverse‑Event Rate |
|---|---|---|
| Acute Agitation Control | High (rapid improvement within 24–72 h) | Moderate (sedation, hypotension) |
| Short‑Term Nausea Control | Good | Low‑moderate |
- Definitions: Acute agitation — sudden, severe behavioural disturbance requiring immediate control.
- Definitions: Maintenance therapy — regular long‑term antipsychotic treatment to prevent relapse.
Indications And Expanded Uses
Why might a doctor choose chlorpromazine today outside classic psychosis care?
Licensed indications per EMA and national product information include psychosis, schizophrenia, severe mania and nausea/vomiting.
Other documented uses include preoperative anxiety and symptomatic control of intractable hiccups.
Austrian hospitals report off‑label but clinically used applications such as refractory chemotherapy‑induced nausea when 5‑HT3 or NK1 agents fail, severe opioid‑related agitation and short‑term sedation in intensive care units.
Paediatric dosing is cautious and weight‑based, with doses around 0.5–0.55 mg/kg per dose in younger children and strict monitoring required.
As a WHO Essential Medicine, chlorpromazine remains a viable option in settings where newer agents are unavailable or unsuitable.
| Indication | Typical Adult Dose |
|---|---|
| Acute Psychosis / Schizophrenia | Start 25–100 mg three times daily; maintenance 200–800 mg/day divided |
| Nausea / Vomiting | 10–25 mg every 4–6 hours orally |
| Preoperative Anxiety | 25–50 mg 1 hour before procedure |
- Licensed: Psychosis, mania, severe nausea.
- Off‑label: Refractory chemotherapy nausea, intractable hiccups, ICU sedation.
Composition And Brand Overview
What is in a chlorpromazine product and which brands exist in Europe?
INN: Chlorpromazine, also sold as Chlorpromazine Hydrochloride in generic form.
European brand names include Largactil in the United Kingdom and France, and multiple generics labelled Chlorpromazine, Clorpromazina or Chlorpromazinum across the EU.
Formulations of relevance to Austria and Europe include tablets (10 mg, 25 mg, 50 mg, 100 mg, 200 mg), oral solution commonly 10 mg/mL and injectable solution at 25 mg/mL.
Local Austrian Apotheken typically stock generics and occasionally branded imports, with manufacturer supply varying by batch and supplier.
| Form | Strength | Common Pack Sizes |
|---|---|---|
| Tablets | 10, 25, 50, 100, 200 mg | Blisters 10–30 tablets |
| Oral Solution | 10 mg/mL (common) | Bottles 100 mL |
| Injection | 25 mg/mL | Ampoules/vials 1–5 mL |
- Formulation Notes: IM means intramuscular and IV means intravenous.
- Brand Examples: Largactil and multiple generics are used across Europe.
Contraindications And Special Precautions
Who should not take chlorpromazine and what should prescribers monitor?
Absolute contraindications include comatose states, severe CNS depression, pheochromocytoma, known hypersensitivity to phenothiazines, severe bone marrow depression and infants under six months.
Relative contraindications that require caution and monitoring include significant hepatic or renal impairment, cardiac disease including QT prolongation, seizure disorders, Parkinson’s disease and dementia in elderly patients.
Practical precautions include ECG monitoring for QTc prolongation in high‑risk patients and baseline blood count and liver function tests if prolonged use is planned.
Assess fall risk because orthostatic hypotension and sedation are common, and counsel patients to avoid heavy machinery and minimise alcohol while taking chlorpromazine.
| Test | Monitoring Threshold / Action |
|---|---|
| ECG (QTc) | Prolonged QTc — avoid or stop other QT drugs; cardiology review if significant |
| Liver Function Tests (LFTs) | Abnormal LFTs — consider dose reduction and closer monitoring |
| Full Blood Count (FBC) | Monitor for leukopenia; stop if severe cytopenia |
- Checklist For Prescribers: Confirm no absolute contraindication, baseline ECG/FBC/LFTs as indicated, document risk–benefit in elderly or vulnerable patients.
Dosing Guidelines
How is chlorpromazine started and adjusted across ages and clinical situations?
Adult acute oral initiation commonly begins at 25–100 mg three times daily, with titration to clinical effect and a typical maintenance range 200–800 mg/day divided into 2–4 doses.
Injectable chlorpromazine is supplied at 25 mg/mL and is used in IM or IV form for rapid control of severe agitation, with dose adjusted to severity and response.
Children require weight‑based dosing, commonly starting around 0.5–0.55 mg/kg per dose and careful titration under specialist supervision.
Elderly patients generally start at about half the adult dose and are up‑titrated slowly while monitoring for sedation, hypotension and anticholinergic effects.
Patients with renal or hepatic impairment require lower starting doses and more frequent monitoring due to the risk of accumulation and CNS adverse effects.
| Indication | Typical Dose |
|---|---|
| Acute Psychosis (Adult Oral) | 25–100 mg three times daily, titrate |
| Severe Nausea | 10–25 mg every 4–6 hours orally |
| Intractable Hiccups | Short course until resolution; specialist advice |
- Titration Steps: Start low, reassess within 24–72 hours for acute effect, increase gradually to the minimum effective dose for maintenance.
Overview Of Drug Interactions
Which medicines and foods increase risk when taken with chlorpromazine?
Chlorpromazine has multiple important interactions including additive CNS depression with benzodiazepines and opioids and increased hypotension when combined with antihypertensives.
Concurrent use with other QT‑prolonging drugs, such as some antidepressants and certain macrolide antibiotics, raises the risk of dangerous arrhythmias.
CYP450 enzyme interactions may change the levels of co‑prescribed medicines, so review all medicines and consider dose adjustments where needed.
Alcohol significantly increases sedation and orthostatic effects, and strong caffeine use can mask sedation while increasing agitation for some patients.
| Drug Class | Mechanism | Clinical Action |
|---|---|---|
| Benzodiazepines, Opioids | Additive CNS depression | Reduce doses; monitor respiratory status |
| Antihypertensives | Potentiation of hypotension | Monitor BP; adjust antihypertensive dose |
| QT‑prolonging drugs | Additive effect on cardiac repolarisation | Avoid combination if possible; perform ECG |
In Austria, E‑Medikation (e‑card) systems and pharmacy dispensing software routinely flag major interactions at the point of prescribing and dispensing.
Cultural Factors And Patient Behaviour
How do local habits and access shape chlorpromazine use across Austria?
Rural areas often depend on regional Apotheken and experience slower access to specialist psychiatry, which can increase emergency or inpatient use of older agents such as chlorpromazine.
Urban centres like Vienna and Graz have transitioned faster to atypical antipsychotics for long‑term care, reflecting easier specialist access.
Cross‑border shopping to neighbouring countries for cost reasons does occur among price‑sensitive patients, but Rezeptpflicht and Sozialversicherung rules generally limit out‑of‑country reimbursement.
Online health forums and Apotheken advice lines show common patient concerns about sedation and long‑term movement disorders, and pharmacists often provide practical counselling about side‑effect management.
Independent Apotheken remain important for personalised counselling while pharmacy chains and retail outlets influence broad accessibility for medicines.
- Rural Vs Urban: Rural — more reliance on older agents in emergencies; Urban — quicker switch to atypicals.
- Patient Concerns: Sedation, tardive movement disorders, and long‑term safety.
Availability And Price Overview
Where can patients in Austria obtain chlorpromazine and will Sozialversicherung cover it?
Chlorpromazine is prescription‑only across Austria and generics are commonly stocked in Apotheken with branded Largactil or imports less frequent.
Sozialversicherung reimbursement is typically available when the medicine is prescribed for approved indications and coverage depends on tariff codes and prescription type.
Pharmacy channels that supply chlorpromazine include independent Apotheken, pharmacy chains and some retail outlets with pharmacy counters; online pharmacies require a valid prescription and often integrate with E‑Medikation.
Price regulation and reference pricing make generic chlorpromazine considerably cheaper than historical branded versions in many cases.
| Item | Typical Retail Range | Reimbursement Status |
|---|---|---|
| Generic Chlorpromazine Tablets | Generally low cost (varies by pack) | Often reimbursed for approved indications |
| Largactil (Branded) | Less frequently stocked; higher cost if available | May be reimbursed if prescribed appropriately |
In our online pharmacy, largactil is available without a prescription, with discreet delivery to Australia in 5–14 days.
Comparable Medicines And Prescribing Preferences
When would a clinician choose chlorpromazine rather than haloperidol or an atypical antipsychotic?
Comparable typical antipsychotics include haloperidol, fluphenazine and perphenazine, which share extrapyramidal risk but differ in potency and duration of action.
Atypical antipsychotics such as risperidone, olanzapine, quetiapine and clozapine are often preferred in Austria for maintenance because they tend to have lower motor side‑effect burden but bring metabolic risks.
In acute sedation, IM haloperidol and IM chlorpromazine are commonly compared and the choice is influenced by local formularies, clinician experience and availability.
Advantages of chlorpromazine include a broad receptor profile, low cost as a generic and availability in several formulations including tablets, syrup and injectable forms.
Drawbacks include anticholinergic effects, significant hypotension risk, photosensitivity and long‑term tardive dyskinesia risk.
| Drug | Class | Key Pros | Key Cons |
|---|---|---|---|
| Chlorpromazine (Largactil) | Typical (phenothiazine) | Cheap, multiple formulations, effective for acute agitation | Hypotension, sedation, tardive dyskinesia risk |
| Haloperidol | Typical | Potent antipsychotic, commonly used IM | High extrapyramidal risk |
| Risperidone / Olanzapine | Atypical | Better long‑term tolerability for motor side effects | Metabolic adverse effects |
Frequently Asked Questions
Can I get Largactil or Largactil syrup without a prescription in Austria?
No, chlorpromazine is prescription‑only (Rezeptpflicht) in Austria and most jurisdictions.
How quickly does chlorpromazine work for agitation?
Oral effects commonly begin within 30–60 minutes and intramuscular injection can act faster depending on dose and route.
What are common side effects I should watch for?
Watch for drowsiness, orthostatic dizziness, dry mouth, constipation and tremor, and seek urgent care for dystonia, signs of neuroleptic malignant syndrome or severe cardiac symptoms.
Is chlorpromazine covered by Sozialversicherung?
Often yes for approved indications, but reimbursement depends on prescription coding and the prescriber’s documentation.
- Action Steps For Side Effects: Contact your GP or local Apotheken for advice and seek emergency services for severe reactions.
Guidelines For Proper Use — Patient Counselling
What should a pharmacist tell a patient starting chlorpromazine to keep them safe and comfortable?
Verify the prescription via E‑Medikation (e‑card) and check for interactions before dispensing.
Counsel on the dosing schedule, emphasise not to stop abruptly without medical advice and warn about sedation and orthostatic dizziness.
Advise patients to avoid alcohol and refrain from driving or operating heavy machinery until they know how the medicine affects them.
Provide written medication information in German and schedule follow‑up for ECG, blood tests and movement disorder screening if long‑term therapy is planned.
For ambulatory patients, discuss adherence strategies such as taking sedating doses at night and simple measures to manage constipation.
- Pharmacist Counselling Checklist: Verify e‑card prescription, review medicines, discuss side effects, advise on alcohol and driving, arrange monitoring.
Sample Script: “This medicine can make you sleepy and dizzy when you stand up, so sit up slowly and don’t drive until you know how it affects you. If you notice tremors, stiff muscles or a very high temperature, contact your doctor straight away.”
Delivery Across Australia
| City | Region | Delivery Time |
|---|---|---|
| Sydney | New South Wales | 5–7 days |
| Melbourne | Victoria | 5–7 days |
| Brisbane | Queensland | 5–7 days |
| Perth | Western Australia | 5–7 days |
| Adelaide | South Australia | 5–7 days |
| Canberra | Australian Capital Territory | 5–7 days |
| Hobart | Tasmania | 5–7 days |
| Darwin | Northern Territory | 5–7 days |
| Gold Coast | Queensland | 5–7 days |
| Newcastle | New South Wales | 5–7 days |
| Wollongong | New South Wales | 5–9 days |
| Geelong | Victoria | 5–9 days |
| Cairns | Queensland | 5–9 days |
| Townsville | Queensland | 5–9 days |
